Eli Lilly Rest of world — Long-Lived Assets increased by 62.9% to $3.52B in Q4 2025 compared to the prior quarter.
An increase suggests significant capital investment in international infrastructure to support future growth, whereas a decrease may indicate asset divestiture or a shift in the company's global operational strategy.
This metric measures the book value of non-current, tangible, and intangible assets located in international geographic...
Similar to 'Property, Plant, and Equipment' or 'Long-Lived Assets by Geography' reported by other multinational pharmaceutical companies.
lly_segment_rest_of_world_long_lived_assets| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | $1.78B | $2.16B | $3.52B |
| QoQ Change | — | +21.0% | +62.9% |
| YoY Change | — | +21.0% | +62.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.